All In Biotech

Drug Trial Radar · NCT06494878

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial

Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 8,805 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

8,805

Planned (sponsor's estimate)

Start

Jun 4, 2026

Primary completion

Sep 2030

Study completion Dec 2030

Sponsor

Lead sponsor
University of CalgaryAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Canadian Institutes of Health Research (CIHR); European Clinical Research Infrastructure Network
First posted
Jul 10, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum individuals with VTE risk factors.

Conditions

  • Venous Thromboembolism
  • Postpartum Period
  • Aspirin
  • Low Molecular Weight Heparin

Interventions

  • AspirinDrug

    75-100 mg taken once daily by mouth.

  • Low-molecular-weight heparinDrug

    Low-molecular-weight heparin injections daily as prescribed by the treating physician.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Symptomatic VTETime frame: 6 weeks

Locations

12 sites in 7 countries. Site status is shown where the registry gives one.

  • Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann

    Brussels, Belgium · Not yet recruiting

  • Foothills Medical Centre

    Calgary, Alberta, Canada · Recruiting

  • The Ottawa Hospital - General Campus

    Ottawa, Ontario, Canada · Not yet recruiting

  • Hvidovre Hospital

    Hvidovre, Capital Region, Denmark · Not yet recruiting

  • CHU de Nancy

    Nancy, France · Not yet recruiting

  • APHP - Hôpital Port Royal

    Paris, France · Not yet recruiting

  • CHU de Saint-Etienne

    Saint-Etienne, France · Not yet recruiting

  • CHU de Toulouse

    Toulouse, France · Not yet recruiting

  • Rotunda Hospital, RCSI Department of Obstetrics and Gynaecology

    Dublin, Ireland · Not yet recruiting

  • UCD Centre for Human Reproduction, The Coombe Hospital

    Dublin, Ireland · Not yet recruiting

  • Amsterdam UMC

    Amsterdam, Netherlands · Not yet recruiting

  • Medical University of Warsaw

    Warsaw, Poland · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.